Bettina C Geertsema-Hoeve
1PUBLICATIONS
0CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (1)
Sort by Publication Date:
|Feb 06, 2025
Multicentre, 26-week, open-label phase 2 trial of the JAK inhibitor filgotinib in Behçet's disease, idiopathic inflammatory myopathies and IgG4-related disease: DRIMID study protocol.Bettina C Geertsema-Hoeve, Jan A M van Laar, Joost Raaphorst
Pageof 1
